nm23-H1 expression in salivary adenoid cystic carcinoma in relation to metastasis and survival

Oncology Reports

Volumn 4, Issue 4, 1997, Pages 707-711

  Ogawa, Ikuko ^a   Takata, Takashi ^b   Miyauchi, Mutsumi ^b   Ito, Hiroshi ^b   Zhao, Ming ^b   Kudo, Yasusei ^b   Nikai, Hiromasa ^b  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adenoid cystic carcinoma; Immunohistochemistry; Metastasis; nm23 H1 Protein; Salivary gland

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; METASTASIS; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; SUPPRESSOR GENE; SURVIVAL RATE;

EID: 0030751846     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.4.4.707     Document Type: Article

References (21)

1. Steeg PS, Bevilacque G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
2. Stahl JA, Leone A, Rosengard AM, Porter L, King CR and Steeg PS: Identification of a second human nm23 gene, nm23-H2. Cancer Res 51:445-449, 1991.
3. Gilles AM, Presecan E, Vonica A and Lascu I: Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexiameric enzyme. J Biol Chem 266: 8784-8789, 1991.
4. Bevilacque G, Sobel ME, Liotta LA and Steeg PS: Association of low nm23 levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
5. Barnes R, Masood S, Barker E, Rosengard AM, Coggin DL, Crowell T, King CR, Porter-Jordan K, Wargotz ES, Liotta LA and Steeg PS: Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patients survival. Am J Pathol 139: 245-250, 1991.
6. Yamaguchi A, Urano T, Goi T, Takeuchi K, Niimoto S, Nakagawara G, Furukawa K and Shiku H: Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 73: 2280-2284, 1994.
7. Ayhan A, Yasui W, Yokozaki H, Kitadai Y and Tahara E: Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas. Virchows Arch (B) 63: 213-218.
8. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, Miyazaki I, Nakagawa G and Shiku H: Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68: 1020-1024, 1993.
9. Nakayama H, Yasui W, Yokozaki H and Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84: 184-190, 1993.
10. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS and Fodstad O: Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression. Cancer Res 52: 6088-6091, 1992.
11. Hailat N, Keim DR, Melhem RF, Zhu X, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Stahler JR and Hanash S: High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and N-myc gene amplification. J Clin Invest 88: 341-345, 1991.
12. Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Takeishi R and Kimura N: Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: lack of prognostic value. Br J Cancer 66: 533-536, 1992.
13. Szanto PA, Luna MA, Tortoledo EM and White RA: Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54: 1062-1069, 1984.
14. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T and Shiku H: Reduced expression of nm23-H1, but not of nm23-H2 is concordant with the frequency of lymph node metastasis of human breast cancer. Int J Cancer 55: 66-71, 1993.
15. MacDonald NJ, De La Rosa A, Benedict MA, Freiji JMP, Krutsch H and Steeg PS: A novel phosphorylation of nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastasis. J Biol Chem 269: 25780-25789, 1993.
16. Kantor JD, McCormick B, Steeg PS and Zetter BR: Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 53: 1971-1973, 1993.
17. Ura H, Denno R and Hirata K: Correlation between nm23 protein and several cell adhesion molecules in human gastric carcinoma. Jpn J Cancer Res 87: 512-517, 1996.
18. Martinez JA, Prevot S, Nordlinger B, Nguyen TMA, Lacarriere Y, Munier A, Lascu I, Vaillant JC, Capeau J and Lacombe ML: Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 37: 712-720, 1995.
19. Fujii K, Yasui W, Shimamoto F, Yokozaki H, Nakayama H, Kajiyama G and Tahara E: Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas. Virchows Arch 426: 355-359, 1995.
20. Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ and Silcocks PB: Nm23 protein expression in ductal in situ and invasive human breast carcinoma. J Natl Carcer Inst 85: 727-731, 1993.
21. Howlett AR, Peterson OW, Steeg PS and Bissell MJ: A novel function for nm23: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest. J Natl Cancer Inst 86: 1838-1844, 1994.